Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Arteriosclerosis, Thrombosis, and Vascular Biology, 2018
Proteins Altered by Surgical Weight Loss Highlight Biomarkers of Insulin Resistance in the Community

Shah R., Hwang S., Yeri A. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

EBioMedicine, 2018
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease

Bom M., Levin E., Driessen R. et al.

Olink Target 96CVDPatient StratificationPlasma

Diabetes and Vascular Disease Research, 2018
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease

Rattik S., Engelbertsen D., Wigren M. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2018
Wound-Healing Markers Revealed by Proximity Extension Assay in Tears of Patients following Glaucoma Surgery

Csősz ?., Tóth N., Deák E. et al.

Olink Target 96OphthalmologyPathophysiologyPatient StratificationTear Fluid

Journal of Controlled Release, 2018
Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release

Sabhachandani P., Sarkar S., Mckenney S. et al.

Olink Target 96OncologyTechnical EvaluationPerfusion Solution From Tumor Spheroids

Diabetes Care, 2018
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort

Schlesinger S., Herder C., Kannenberg J. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologySerum

Therapeutic Drug Monitoring, 2018
Targeted Proteomic Analysis Detects Acute T Cell–Mediated Kidney Allograft Rejection in Belatacept-Treated Patients

van der Zwan M., Hesselink D., Clahsen-van Groningen M. et al.

Olink Target 96Immunological & Inflammatory DiseasesNephrologyPatient StratificationSerum

Biomarkers, 2018
The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients

Vroegindewey M., Oemrawsingh R., Kardys I. et al.

Olink Target 96CVDPathophysiologySerum

Clinical Proteomics, 2018
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Enroth S., Berggrund M., Lycke M. et al.

Olink Target 96OncologyPatient StratificationPlasma

Journal of Nephrology, 2018
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease

Feldreich T., Nowak C., Fall T. et al.

Olink Target 96CVDNephrologyPatient StratificationPlasma

Analytical Biochemistry, 2018
Protein measurements in venous plasma, earlobe capillary plasma and in plasma stored on filter paper

Siart B., de Oliveira F., Shen Q. et al.

Olink Target 96Technical StudiesTechnical EvaluationPlasmaDried Blood Spots

Molecular Oncology, 2018
Protein profiling of fine‐needle aspirates reveals subtype‐associated immune signatures and involvement of chemokines in breast cancer

Franzén B., Alexeyenko A., Kamali‐Moghaddam M. et al.

Olink Target 96OncologyPatient StratificationFine Needle Aspirate

Journal of the European Academy of Dermatology and Venereology, 2018
Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

Vossen A., van der Zee H., Davelaar N. et al.

Olink Target 96Dermatological DiseasesPathophysiologyCell Culture Supernatant

European Heart Journal, 2018
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation

Chua W., Purmah Y., Cardoso V. et al.

Olink Target 96CVDSurrogate EndpointPlasma

ERJ Open Research, 2018
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension

Bouzina H., Rådegran G.

Olink Target 96CVDPatient StratificationPlasma

PLOS ONE, 2018
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

Gezelius E., Flou Kristensen A., Bendahl P. et al.

Olink Target 96OncologyCVDPatient StratificationPlasma

British Journal of Cancer, 2018
Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis

Qian J., Tikk K., Weigl K. et al.

Olink Target 96OncologyPathophysiologyPatient StratificationPlasma

The FEBS Journal, 2018
The biology of the cell – insights from mass cytometry

Brodin P.

Immunological & Inflammatory DiseasesReview/editorial

JCI Insight, 2018
Inhibition of profibrotic microRNA-21 affects platelets and their releasate

Barwari T., Eminaga S., Mayr U. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of the American Heart Association, 2018
Markers of Basement Membrane Remodeling Are Associated With Higher Mortality in Patients With Known Atherosclerosis

Holm Nielsen S., Tengryd C., Edsfeldt A. et al.

Olink Target 96CVDPathophysiologySerum

4265 publications